Skip to search formSkip to main contentSkip to account menu

Calcineurin inhibitor

Known as: Calcineurin Antagonists, Protein Phosphatase 2B Inhibitors, Calcineurin Blockers 
Compounds that inhibit or block the PHOSPHATASE activity of CALCINEURIN.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Background: Long-term efficacy and safety of de novo use of the mammalian target of rapamycin inhibitors (mTORi) have been… 
2014
2014
The ubiquitin/proteasome system plays significant and important roles in the regulation of metabolism of various proteins. The… 
2013
2013
The history of immunosuppressive drugs is linked to both the evolution of scientific under‐ standing of inflammatory diseases and… 
Review
2009
Review
2009
Membranous nephropathy (MN) is a common immune-mediated glomerular disease and one of the leading causes of nephrotic syndrome in… 
Review
2007
Review
2007
Purpose of reviewDue to their nephrotoxic potential, strategies of avoidance, minimization or withdrawal of calcineurin… 
Review
2006
Review
2006
Purpose of reviewThe aim of this review is to report on the current state of calcineurin inhibitor-sparing therapies. The… 
2001
2001
Background. Calcineurin inhibitors (CNI) and azole antifungal agents have been reported to interact in a disparate manner. The… 
1999
1999
BACKGROUND Nephrotoxicity is a frequently encountered adverse effect of calcineurin inhibitors (cyclosporine and tacrolimus…